Roivant Sciences Announces Pricing of Upsized Public Offering of Common Shares Feb 2, 2023 09:14PM
Roivant Sciences (ROIV) Announces Proposed $150M Share Offering Feb 1, 2023 04:05PM
Roivant Sciences Announces Proposed Public Offering of Common Shares Feb 1, 2023 04:05PM
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2022 on Monday, February 13, 2023 Jan 30, 2023 08:00AM
Roivant to Report Financial Results for the Quarter Ended December 31, 2021 on Monday, February 14, 2022 Feb 7, 2022 07:00AM


Oct 1, 2021 08:00AM Roivant Sciences Announces Close of Business Combination with Montes Archimedes Acquisition Corp. and Concurrent PIPE Financing